TFS CAPITAL LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 158 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$689,000
-16.3%
45,032
-28.4%
0.18%
+21.9%
Q2 2016$823,000
+39.5%
62,909
+23.5%
0.15%
+135.9%
Q4 2015$590,000
-50.3%
50,937
-48.2%
0.06%
-44.8%
Q2 2015$1,187,000
+42.8%
98,387
+53.4%
0.12%
+61.1%
Q3 2014$831,000
+16.5%
64,131
+37.9%
0.07%
+28.6%
Q2 2014$713,00046,5180.06%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders